AbbVie
AbbVie Partners With ConcertAI, Caris Life Sciences to Advance Precision Oncology Drug Development
The firm will use Caris and ConcertAI's clinical and genomic databases and AI insights to guide drug development and improve clinical trials.
Alliance for Genomic Discovery Adds Major Biopharma Partners to Help Fund WGS-Based Biobank
Funding from AbbVie, Amgen, AstraZeneca, Bayer, and Merck will enable DeCode Genetics to sequence an additional 215,000 samples for the alliance.
The biopharma companies are looking to accelerate the completion of UK Biobank Exome Sequencing Consortium data analysis to aid drug discovery.
Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project
The consortium aims to harmonize the use of homologous recombination deficiency as a biomarker to guide certain treatment types in cancer patients.
New Drug Approvals More Likely With Supporting Human Genetic Evidence
AbbVie researchers validated and extended a previous study to find different types of genetic evidence have varying influences on approval prospects.